Jacob Pieter Noordzij

Dr. Jacob Pieter Noordzij


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
JNJacob Pieter Noordzij
Jacob Pieter Noordzij
SLStephanie L. Lee
Stephanie L. Lee
VBVictor J. Bernet
Victor J. Bernet
RPRichard J. Payne
Richard J. Payne
SCSeth M. Cohen
Seth M. Cohen
MDMary S. Dietrich
Mary S. Dietrich
Monitoring for hypocalcemia after thyroidectomy, using only symptoms and serum calcium levels, can delay the discharge of patients who will remain normocalcemic and can delay the treatment of hypocalcemic patients. We conducted a systematic search for articles describing use of parathyroid hormone (PTH) assay, checked within hours of completing thyroidectomy, to predict postoperative symptomatic hypocalcemia. Studies were excluded if all patients were treated with postoperative calcium, or if early PTH values were used to alter management of the patient. Individual patient data (perioperative PTH and calcium levels, development of hypocalcemia) were obtained for 457 patients from the corresponding authors of 9 studies and pooled to yield the following results. PTH, checked at three time periods after removal of the thyroid gland (0 to 20 minutes, 1 to 2 hours, and 6 hours), was substantially lower in patients who became hypocalcemic compared with those who remained normocalcemic. The accuracy of PTH in determining hypocalcemia increased with time and was excellent when checked 1 to 6 hours postoperatively. A single PTH threshold (65% decrease compared with preoperative level), checked 6 hours after completing thyroidectomy, had a sensitivity of 96.4% and specificity of 91.4% in detecting postoperative hypocalcemia. PTH assay, when checked 1 to 6 hours after thyroidectomy, has excellent accuracy in determining which patients will become symptomatically hypocalcemic. Routine use of this assay should be considered because it may allow earlier discharge of the normocalcemic patient and earlier identification of patients requiring treatment of postthyroidectomy hypocalcemia.

4 February 2015 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
RRRichard D Riley
Richard D Riley
IAIkhlaaq Ahmed
Ikhlaaq Ahmed
JEJoie Ensor
Joie Ensor
YTYemisi Takwoingi
Yemisi Takwoingi
AKAmanda Kirkham
Amanda Kirkham
JDJonathan J Deeks
Jonathan J Deeks
Primary studies examining the accuracy of a continuous test evaluate its sensitivity and specificity at one or more thresholds. Meta-analysts then usually perform a separate meta-analysis for each threshold. However, the number of studies available for each threshold is often very different, as primary studies are inconsistent in the thresholds reported. Furthermore, of concern is selective reporting bias, because primary studies may be less likely to report a threshold when it gives low sensitivity and/or specificity estimates. This may lead to biased meta-analysis results. We developed an exploratory method to examine the potential impact of missing thresholds on conclusions from a test accuracy meta-analysis. Our method identifies studies that contain missing thresholds bounded between a pair of higher and lower thresholds for which results are available. The bounded missing threshold results (two-by-two tables) are then imputed, by assuming a linear relationship between threshold value and each of logit-sensitivity and logit-specificity. The imputed results are then added to the meta-analysis, to ascertain if original conclusions are robust. The method is evaluated through simulation, and application made to 13 studies evaluating protein:creatinine ratio (PCR) for detecting proteinuria in pregnancy with 23 different thresholds, ranging from one to seven per study. The simulation shows the imputation method leads to meta-analysis estimates with smaller mean-square error. In the PCR application, it provides 50 additional results for meta-analysis and their inclusion produces lower test accuracy results than originally identified. For example, at a PCR threshold of 0.16, the summary specificity is 0.80 when using the original data, but 0.66 when also including the imputed data. At a PCR threshold of 0.25, the summary sensitivity is reduced from 0.95 to 0.85 when additionally including the imputed data. The imputation method is a practical tool for researchers (often non-statisticians) to explore the potential impact of missing threshold results on their meta-analysis conclusions. Software is available to implement the method. In the PCR example, it revealed threshold results are vulnerable to the missing data, and so stimulates the need for advanced statistical models or, preferably, individual patient data from primary studies.

1 July 2019 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
ASAnita Sulibhavi
Anita Sulibhavi
MRMatthew Rohlfing
Matthew Rohlfing
SJScharukh M. Jalisi
Scharukh M. Jalisi
DMDavid B. McAneny
David B. McAneny
GDGerard M. Doherty
Gerard M. Doherty
JNJacob Pieter Noordzij
Jacob Pieter Noordzij

14 July 2021 in Cancers
Verified
Journal Article
Open access
PDF file
ABAshank Bains
Ashank Bains
TMTaha Mur
Taha Mur
NWNathan Wallace
Nathan Wallace
JNJacob Pieter Noordzij
Jacob Pieter Noordzij
The role of vitamin D in modulating several cancer-related pathways has received an increasing amount of attention in the past several years. Previous literature has found an abundance of evidence of vitamin D exerting an anti-proliferative, anti-inflammatory, and pro-differentiation effect in various types of cancers including breast, colon, prostate, and pancreatic cancer. Although the link between vitamin D and thyroid cancer remains controversial, both biochemical evidence and clinical studies have attempted to establish a link between papillary thyroid carcinoma (PTC) and vitamin D status. Furthermore, the use of vitamin D as a prognostic marker has received increased attention, both in regards to clinical outcomes and cancer staging. In this review, we briefly discuss the metabolism and proposed mechanism of action of vitamin D in the context of PTC, and explore links between modulators in the vitamin D pathway and progression of PTC. We provide evidence from both clinical studies as well as molecular studies of metabolic targets, including vitamin D receptor and activating enzymes exerting an effect on PTC tissue, which indicate that vitamin D may play a significant prognostic role in PTC.

25 January 2018 in Dysphagia
Verified
Journal Article
Closed access
PDF file
JDJoseph D. DePietro
Joseph D. DePietro
SRSamuel Rubin
Samuel Rubin
DSDaniel J. Stein
Daniel J. Stein
HGHadas Golan
Hadas Golan
JNJacob Pieter Noordzij
Jacob Pieter Noordzij

1 October 2013 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
JDJoseph D. DePietro
Joseph D. DePietro
DSDaniel J. Stein
Daniel J. Stein
NCNathan Calloway
Nathan Calloway
SCSeth M. Cohen
Seth M. Cohen
JNJacob Pieter Noordzij
Jacob Pieter Noordzij